Statement of Changes in Beneficial Ownership (4)
March 19 2015 - 6:25PM
Edgar (US Regulatory)
FORM 4
[
X
]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Whitcup Scott M
|
2. Issuer Name
and
Ticker or Trading Symbol
ALLERGAN INC
[
AGN
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
Executive VP, R&D, CSO
|
(Last)
(First)
(Middle)
2525 DUPONT DRIVE
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
3/17/2015
|
(Street)
IRVINE, CA 92612
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
2/20/2015
|
|
G
|
V
|
9766
|
D
|
$0
|
7409
|
D
|
|
Common Stock
|
3/17/2015
|
|
A
|
|
11273.669
(1)
|
A
|
$0
|
18682.669
|
D
|
|
Common Stock
|
3/17/2015
|
|
D
|
|
18682.669
(2)
|
D
|
(2)
|
0
|
D
|
|
Common Stock
|
3/17/2015
|
|
D
|
|
1739.1061
(2)
|
D
|
(2)
|
0
|
I
|
By Esop
|
Common Stock
|
3/17/2015
|
|
D
|
|
1709.7067
(2)
|
D
|
(2)
|
0
|
I
|
By 401(k)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Employee Stock Option (Right to Buy)
|
$58.55
|
3/17/2015
|
|
D
|
|
|
89200
(3)
|
(4)
|
2/2/2017
|
Common Stock
|
89200
|
(4)
|
0
|
D
|
|
Employee Stock Option (Right to Buy)
|
$64.47
|
3/17/2015
|
|
D
|
|
|
105500
|
(4)
|
2/14/2018
|
Common Stock
|
105500
|
(4)
|
0
|
D
|
|
Employee Stock Option (Right to Buy)
|
$40.16
|
3/17/2015
|
|
D
|
|
|
130400
|
(4)
|
2/20/2019
|
Common Stock
|
130400
|
(4)
|
0
|
D
|
|
Employee Stock Option (Right to Buy)
|
$59.13
|
3/17/2015
|
|
D
|
|
|
92600
|
(4)
|
2/22/2020
|
Common Stock
|
92600
|
(4)
|
0
|
D
|
|
Employee Stock Option (Right to Buy)
|
$75.58
|
3/17/2015
|
|
D
|
|
|
120000
|
(4)
|
2/17/2021
|
Common Stock
|
120000
|
(4)
|
0
|
D
|
|
Employee Stock Option (Right to Buy)
|
$105.87
|
3/17/2015
|
|
D
|
|
|
60000
|
(4)
|
2/21/2023
|
Common Stock
|
60000
|
(4)
|
0
|
D
|
|
Employee Stock Option (Right to Buy)
|
$87.91
|
3/17/2015
|
|
D
|
|
|
25000
|
(4)
|
2/17/2022
|
Common Stock
|
25000
|
(4)
|
0
|
D
|
|
Employee Stock Option (Right to Buy)
|
$87.91
|
3/17/2015
|
|
D
|
|
|
67000
|
(4)
|
2/17/2022
|
Common Stock
|
67000
|
(4)
|
0
|
D
|
|
Employee Stock Option (Right to Buy)
|
$125.07
|
3/17/2015
|
|
D
|
|
|
58815
|
(4)
|
2/21/2024
|
Common Stock
|
58815
|
(4)
|
0
|
D
|
|
Explanation of Responses:
|
(
1)
|
Represents 11,271 performance-based restricted stock units granted on October 29, 2014 and 2.6690 dividend equivalent rights acquired with respect to each vested restricted stock unit (collectively, the "RSUs"). The RSUs vested in full on the Effective Date pursuant to the terms of the Merger Agreement (each as defined below).
|
(
2)
|
Pursuant to that certain Agreement and Plan of Merger dated November 16, 2014, (the "Merger Agreement") by and among the Issuer, Actavis, Plc ("Actavis) and a wholly-owned subsidiary of Actavis, the Issuer became an indirect wholly-owned subsidiary of Actavis upon consummation of the merger (the "Effective Date"). Each share of common stock was disposed of in exchange for $129.22 cash plus 0.3683 of an Actavis ordinary share, having a market value of $307.51 per share on the Effective Date.
|
(
3)
|
The option was previously reported as covering 44,600 shares at an exercise price of $117.10. The Issuer effected a two-for-one stock split on June 22, 2007, which resulted in 89,200 shares held by the reporting person at an exercise price of $58.55.
|
(
4)
|
Each option vested in full on the Effective Date and was cancelled in exchange for a cash payment equal to the number of shares subject to the option immediately prior to the merger, multiplied by the difference between (i) 0.3683 times $294.1509 (which represents the 10-day volume weighted average price of Actavis stock starting on the 11th trading day prior to the closing) plus $129.22 and (ii) the exercise price of the option, subject to the applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Whitcup Scott M
2525 DUPONT DRIVE
IRVINE, CA 92612
|
|
|
Executive VP, R&D, CSO
|
|
Signatures
|
/s/ Matthew J. Maletta, attorney-in-fact for Scott M. Whitcup
|
|
3/19/2015
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Allergan (NYSE:AGN)
Historical Stock Chart
From Sep 2024 to Oct 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Allergan plc (New York Stock Exchange): 0 recent articles
More Allergan Inc News Articles